메뉴 건너뛰기




Volumn 7, Issue 8, 2012, Pages

GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; INTEGRIN RECEPTOR;

EID: 84865055308     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043255     Document Type: Article
Times cited : (153)

References (31)
  • 1
    • 33747713246 scopus 로고    scopus 로고
    • Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
    • Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, et al. ((2006)) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:: 315--317.
    • (2006) Cytotherapy , vol.8 , pp. 315-317
    • Dominici, M.1    Le, B.K.2    Mueller, I.3    Slaper-Cortenbach, I.4    Marini, F.5
  • 2
    • 0028340485 scopus 로고
    • The mesengenic process
    • Caplan AI, ((1994)) The mesengenic process. ClinPlastSurg 21:: 429--435.
    • (1994) ClinPlastSurg , vol.21 , pp. 429-435
    • Caplan, A.I.1
  • 3
    • 34249290435 scopus 로고    scopus 로고
    • Mesenchymal stem cells for treating GVHD: in-vivo fate and optimal dose
    • Subbanna PK, ((2007)) Mesenchymal stem cells for treating GVHD: in-vivo fate and optimal dose. MedHypotheses 69:: 469--470.
    • (2007) MedHypotheses , vol.69 , pp. 469-470
    • Subbanna, P.K.1
  • 4
    • 77955820309 scopus 로고    scopus 로고
    • Concise review: hitting the right spot with mesenchymal stromal cells
    • Tolar J, Le BK, Keating A, Blazar BR, ((2010)) Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 28:: 1446--1455.
    • (2010) Stem Cells , vol.28 , pp. 1446-1455
    • Tolar, J.1    Le, B.K.2    Keating, A.3    Blazar, B.R.4
  • 5
    • 77958499413 scopus 로고    scopus 로고
    • REGULATION (EC) No 1394/2007 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004
    • EuropeanCommission
    • EuropeanCommission ((2007)) REGULATION (EC) No 1394/2007 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union 50:: 121--137.
    • (2007) Official Journal of the European Union , vol.50 , pp. 121-137
  • 6
    • 84859745736 scopus 로고    scopus 로고
    • Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components
    • Fekete N, Gadelorge M, Furst D, Maurer C, Dausend J, et al. ((2012)) Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy 14:: 540--54.
    • (2012) Cytotherapy , vol.14 , pp. 540-554
    • Fekete, N.1    Gadelorge, M.2    Furst, D.3    Maurer, C.4    Dausend, J.5
  • 7
    • 84874195656 scopus 로고    scopus 로고
    • Bundesärztekammer (2010) Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). http://wwwbundesaerztekammerde/downloads/RiliHaemotherapie2010pdf Gesamtnovelle 2005.
  • 8
    • 74549165987 scopus 로고    scopus 로고
    • Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes
    • Initiative ISCB
    • Initiative ISCB, ((2009)) Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev 5:: 301--314.
    • (2009) Stem Cell Rev , vol.5 , pp. 301-314
  • 9
    • 74449089364 scopus 로고    scopus 로고
    • Effect of functionalised fluorescence-labelled nanoparticles on mesenchymal stem cell differentiation
    • Tautzenberger A, Lorenz S, Kreja L, Zeller A, Musyanovych A, et al. ((2010)) Effect of functionalised fluorescence-labelled nanoparticles on mesenchymal stem cell differentiation. Biomaterials 31:: 2064--2071.
    • (2010) Biomaterials , vol.31 , pp. 2064-2071
    • Tautzenberger, A.1    Lorenz, S.2    Kreja, L.3    Zeller, A.4    Musyanovych, A.5
  • 11
    • 84874222012 scopus 로고    scopus 로고
    • FDA (2011) PART 1271, HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS. Code of Federal Regulations 8: www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart = 1271.
  • 12
    • 84874219951 scopus 로고    scopus 로고
    • FDA (2011) Guidance for Industry- Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). http://wwwfdagov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/UCM285223pdf.
  • 14
    • 33845800093 scopus 로고    scopus 로고
    • COMMISSION DIRECTIVE 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use
    • EuropeanCommission
    • EuropeanCommission ((2003)) COMMISSION DIRECTIVE 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use. Official Journal of the European Union 46:: 22--26.
    • (2003) Official Journal of the European Union , vol.46 , pp. 22-26
  • 15
    • 4043144681 scopus 로고    scopus 로고
    • DIRECTIVE 2002/98/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribu- tionofhumanbloodandbloodcomponentsandamendingDirective2001/83/EC
    • EuropeanCommission
    • EuropeanCommission ((2002)) DIRECTIVE 2002/98/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribu- tionofhumanbloodandbloodcomponentsandamendingDirective2001/83/EC. Official Journal of the European Union 45:: 30--40.
    • (2002) Official Journal of the European Union , vol.45 , pp. 30-40
  • 17
    • 77949890037 scopus 로고    scopus 로고
    • Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation
    • Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, et al. ((2010)) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115:: 1549--1553.
    • (2010) Blood , vol.115 , pp. 1549-1553
    • Tarte, K.1    Gaillard, J.2    Lataillade, J.J.3    Fouillard, L.4    Becker, M.5
  • 18
    • 49649096100 scopus 로고    scopus 로고
    • Phenotypic Characterization of Mesenchymal Stem Cells from Various Tissues
    • Rojewski MT, Weber BM, Schrezenmeier H, ((2008)) Phenotypic Characterization of Mesenchymal Stem Cells from Various Tissues. TransfusMedHemother 35:: 168--184.
    • (2008) TransfusMedHemother , vol.35 , pp. 168-184
    • Rojewski, M.T.1    Weber, B.M.2    Schrezenmeier, H.3
  • 19
    • 70349808974 scopus 로고    scopus 로고
    • Phenotypic characterization of distinct human bone marrow-derived MSC subsets
    • Buhring HJ, Treml S, Cerabona F, de ZP, Kanz L, et al. ((2009)) Phenotypic characterization of distinct human bone marrow-derived MSC subsets. AnnNYAcadSci 1176:: 124--134.
    • (2009) AnnNYAcadSci , vol.1176 , pp. 124-134
    • Buhring, H.J.1    Treml, S.2    Cerabona, F.3    de, Z.P.4    Kanz, L.5
  • 20
    • 42049088752 scopus 로고    scopus 로고
    • Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody
    • Battula VL, Treml S, Abele H, Buhring HJ, ((2008)) Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody. Differentiation 76:: 326--336.
    • (2008) Differentiation , vol.76 , pp. 326-336
    • Battula, V.L.1    Treml, S.2    Abele, H.3    Buhring, H.J.4
  • 21
    • 0033485750 scopus 로고    scopus 로고
    • Donor variation in the growth properties and osteogenic potential of human marrow stromal cells
    • Phinney DG, Kopen G, Righter W, Webster S, Tremain N, et al. ((1999)) Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75:: 424--436.
    • (1999) J Cell Biochem , vol.75 , pp. 424-436
    • Phinney, D.G.1    Kopen, G.2    Righter, W.3    Webster, S.4    Tremain, N.5
  • 22
    • 34447283203 scopus 로고    scopus 로고
    • Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering
    • Siddappa R, Licht R, van Blitterswijk C, de Boer J, ((2007)) Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25:: 1029--1041.
    • (2007) J Orthop Res , vol.25 , pp. 1029-1041
    • Siddappa, R.1    Licht, R.2    van Blitterswijk, C.3    de Boer, J.4
  • 23
    • 0345768562 scopus 로고    scopus 로고
    • Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study
    • Arpornmaeklong P, Kochel M, Depprich R, Kubler NR, Wurzler KK, ((2004)) Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study. Int J Oral Maxillofac Surg 33:: 60--70.
    • (2004) Int J Oral Maxillofac Surg , vol.33 , pp. 60-70
    • Arpornmaeklong, P.1    Kochel, M.2    Depprich, R.3    Kubler, N.R.4    Wurzler, K.K.5
  • 24
    • 33750515870 scopus 로고    scopus 로고
    • Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics
    • Vogel JP, Szalay K, Geiger F, Kramer M, Richter W, et al. ((2006)) Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. Platelets 17:: 462--469.
    • (2006) Platelets , vol.17 , pp. 462-469
    • Vogel, J.P.1    Szalay, K.2    Geiger, F.3    Kramer, M.4    Richter, W.5
  • 25
    • 80052307742 scopus 로고    scopus 로고
    • Human platelet lysate supports ex vivo expansion and enhances osteogenic differentiation of human bone marrow-derived mesenchymal stem cells
    • Xia W, Li H, Wang Z, Xu R, Fu Y, et al. ((2011)) Human platelet lysate supports ex vivo expansion and enhances osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Biol Int 35:: 639--643.
    • (2011) Cell Biol Int , vol.35 , pp. 639-643
    • Xia, W.1    Li, H.2    Wang, Z.3    Xu, R.4    Fu, Y.5
  • 26
    • 70349850496 scopus 로고    scopus 로고
    • Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow
    • Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, et al. ((2009)) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27:: 2331--2341.
    • (2009) Stem Cells , vol.27 , pp. 2331-2341
    • Bieback, K.1    Hecker, A.2    Kocaomer, A.3    Lannert, H.4    Schallmoser, K.5
  • 27
    • 57949102222 scopus 로고    scopus 로고
    • How do mesenchymal stromal cells exert their therapeutic benefit?
    • Horwitz EM, Dominici M, ((2008)) How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 10:: 771--774.
    • (2008) Cytotherapy , vol.10 , pp. 771-774
    • Horwitz, E.M.1    Dominici, M.2
  • 28
    • 70350719377 scopus 로고    scopus 로고
    • Comparison of cytokine expression in mesenchymal stem cells from human placenta, cord blood, and bone marrow
    • Hwang JH, Shim SS, Seok OS, Lee HY, Woo SK, et al. ((2009)) Comparison of cytokine expression in mesenchymal stem cells from human placenta, cord blood, and bone marrow. JKorean MedSci 24:: 547--554.
    • (2009) JKorean MedSci , vol.24 , pp. 547-554
    • Hwang, J.H.1    Shim, S.S.2    Seok, O.S.3    Lee, H.Y.4    Woo, S.K.5
  • 29
    • 64549145804 scopus 로고    scopus 로고
    • Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression
    • Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, et al. ((2009)) Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoSOne 4:: e4992.
    • (2009) PLoSOne , vol.4
    • Spaeth, E.L.1    Dembinski, J.L.2    Sasser, A.K.3    Watson, K.4    Klopp, A.5
  • 30
    • 49649083074 scopus 로고    scopus 로고
    • The Stromal Activity of Mesenchymal Stromal Cells
    • Wagner W, Saffrich R, Ho AD, ((2008)) The Stromal Activity of Mesenchymal Stromal Cells. TransfusMedHemother 35:: 185--193.
    • (2008) TransfusMedHemother , vol.35 , pp. 185-193
    • Wagner, W.1    Saffrich, R.2    Ho, A.D.3
  • 31
    • 77952551255 scopus 로고    scopus 로고
    • Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli
    • Zhukareva V, Obrocka M, Houle JD, Fischer I, Neuhuber B, ((2010)) Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli. Cytokine 50:: 317--321.
    • (2010) Cytokine , vol.50 , pp. 317-321
    • Zhukareva, V.1    Obrocka, M.2    Houle, J.D.3    Fischer, I.4    Neuhuber, B.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.